|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and more than 2,300 generic ingredients from more than 1,700 branded and generic pharmaceutical companies, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: eszopiclone
Summary for Generic Name: eszopiclone
|
Tentative approvals for ESZOPICLONE
| ||||||||||||||||||||||||||||
Clinical Trials for: eszopicloneTreatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone Status: Completed Condition: Parkinson's Disease; Insomnia The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia Status: Completed Condition: Depression; Anxiety; Insomnia Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients Status: Completed Condition: Sleep Deprivation Eszopiclone for the Treatment of Posttraumatic Stress Disorder Status: Recruiting Condition: Posttraumatic Stress Disorders Eszopiclone in the Treatment of Insomnia and Fibromyalgia Status: Completed Condition: Fibromyalgia; Insomnia Hypnotics to Improve Polysomnography Yield: Eszopiclone vs Ramelteon? Status: Completed Condition: Obstructive Sleep Apnea Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||||||||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Patented / Exclusive Use | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET; ORAL | 021476 | Dec 15, 2004 | RX | Yes | <disabled> | REVISIONS TO LABELING BASED ON DATA SUBMITTED IN RESPONSE TO PEDIATRIC WRITTEN REQUEST | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET; ORAL | 021476 | Dec 15, 2004 | RX | Yes | <disabled> | PEDIATRIC EXCLUSIVITY | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET; ORAL | 021476 | Dec 15, 2004 | RX | Yes | 6,319,926*PED | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sunovion Pharms Inc | LUNESTA | eszopiclone | TABLET; ORAL | 021476 | Dec 15, 2004 | RX | Yes | 6,444,673*PED | Y | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc